Company Profile

THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC
BSE530.25-8.5 (-1.58 % )
PREV CLOSE (Rs.) 538.75
OPEN PRICE (Rs.) 540.05
BID PRICE (QTY) 530.35 (15 )
OFFER PRICE (QTY) 532.50 (10 )
VOLUME 145
TODAY'S LOW / HIGH (Rs.)530.25 540.05
52 WK LOW / HIGH (Rs.)482 725
NSE529.45 -12.2 (-2.25 % )
PREV CLOSE(Rs.) 541.65
OPEN PRICE (Rs.) 545.95
BID PRICE (QTY) 529.05 (5 )
OFFER PRICE (QTY) 529.95 (5 )
VOLUME 10483
TODAY'S LOW / HIGH(Rs.) 528.10 545.95
52 WK LOW / HIGH (Rs.)485 711

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.7688625
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 29.00
ROCE (%) 33.55
Incorporation Year : 2000

Management Info :

A Velumani - Chairman A Velumani - Managing Director

Registered Office :

Address : D - 37/1, Ttc Industrial Area,M I D C,Turbhe,
Navi Mumbai,
Maharashtra-400703

Phone : 91-022-27622762

Website : www.thyrocare.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
12Feb02-12-2019$ Outcome of Board Meeting Outcome of Board Meeting
This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and Consolidated) for the Quarter / Nine Month Period ended December 31, 2018. The Stand-alone and Consolidated unaudited financial results for the Quarter / Nine Month Period ended December 31, 2018, along with the Limited Review Reports, are attached pursuant to Regulation 33 (3) (a) to (c) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform that the meeting commenced at 17.30 hours and ended at 19.45 hours today, the 9th February 2019.
This is to inform you that the Board of Directors of the Compan..
31Jan01-31-2019$Thyrocare Technologies informs about investor conference Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that Sachin Salvi, General Manager - Finance would be participating at Build India, New India Investor Conference organized by Antique Stock Broking, at Hotel Sofitel BKC, Mumbai, on Tuesday, 12th February 2019, where representatives of various fund houses would be meeting him, from 10.00 AM to 2.00 PM.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
31Jan01-31-2019$Thyrocare Technologies informs about investors conference Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that Dr. A. Velumani, Chairman & Managing Director, would be participating at 10th Enterprising India Investors Conference organized by IIFL- Institutional Equities, at Hotel Trident BKC, Mumbai, on Wednesday, 13th February 2019, where representatives of various fund houses would be meeting him, from 02.00 PM to 6.00 PM.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
13Dec12-13-2018$Thyrocare Technologies informs about analyst meet Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chainnan, Managing Director & CEO, Anand Velumani, Director of the company’s wholly owned subsidiary, Nueclear Healthcare, Dr. Caesar Sengupta, Vice-President-Operations and Sachin Salvi, General Manager-Finance, at the office by 11.00 AM on Monday, December 17, 2018. There could be last minute change in the timings or in the names of the officers the analysts would be meeting. No un-published Price-Sensitive Information will be shared during the above meeting.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
03Dec12-03-2018$Thyrocare Technologies informs about investor meet Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that Robert Harvey and Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with Anand Velumani, Director of the company’s wholly owned subsidiary, Nueclear Healthcare, and Aditya Shinde, Deputy General Manager- Finance at Hotel Trident, BKC by 09.00 AM on Wednesday, December 05, 2018. There could be last minute change in the names of Analysts or in the timings. It is also informed that no unpublished Price-Sensitive Information will be shared during the meetings.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit224.4960.38
Gross Profit 344.2 1479.64
Operating Profit 383.81626.41
Net Sales 881.23317.94
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Kovai Medical Center (BSE)
 795.00 (3.54%)
M.Cap ( in Cr)
869.91
Dr Lal Pathlabs (BSE)
 1090.00 (1.61%)
M.Cap ( in Cr)
9080.07
Apollo Hospital Ent. (BSE)
 1151.00 (0.37%)
M.Cap ( in Cr)
16000.78
Tejnaksh Healthcare (BSE)
 61.35 (5.87%)
M.Cap ( in Cr)
62.26
Kaya Ltd. (BSE)
 685.00 (0.31%)
M.Cap ( in Cr)
894.89
Shareholding Pattern More
NON-INSTITUTION 8.25 %
PROMOTERS 65.12 %
MUTUAL FUNDS/UTI 14.33 %
FI/BANKS/INSURANCE 0.33 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested